Unitaid, CHAI, and Wits RHI enter into a landmark agreement with Dr. Reddy’s to make HIV prevention tool lenacapavir affordable in LMICs - Unitaid
We all need some good news
👏🏽👏🏽👏🏽
“The revolutionary HIV prevention tool, injectable lenacapavir, will be available at a cost of US$40 a year in 120 low- and middle-income countries starting in 2027”
@unitaid.bsky.social CHAI Wits RHI
unitaid.org/news-blog/le...
24.09.2025 11:32 — 👍 127 🔁 37 💬 0 📌 4
100 years of insulin in 15 minutes
In the 1970s, it took 8,000 pounds of pancreas glands from 23,500 animals just to make a single pound of insulin.
18.09.2025 20:05 — 👍 44 🔁 10 💬 3 📌 0
Roche SBX very high throughout NGS instrument is about to disrupt the short reads sequencing space. But is the data quality good enough? Read all about it at albertvilella.substack.com
14.09.2025 16:38 — 👍 10 🔁 2 💬 0 📌 0
This makes me wonder about the premiums we pay on other Sigma products.
Take advantage of the web-only promotion !
12.09.2025 18:48 — 👍 6 🔁 2 💬 1 📌 1
OUR BLESSED mixed models vs THEIR BARABAROUS fixed effects
OUR GLORIOUS Mundlak device vs THEIR WICKED demeaning
OUR GREAT variance components vs THEIR PRIMITIVE dummy variables
OUR NOBLE partial pooling vs THEIR BACKWARD unbiased estimates
OUR HEROIC maximum likelihoos vs THEIR BRUTISH least squares
I could have sworn I created this before on our Previous Parish, but couldn't find it so made it fresh.
I present:
OUR BLESSED mixed models // THEIR BARBAROUS fixed effects
09.09.2025 13:49 — 👍 103 🔁 25 💬 4 📌 2
A reminder that the mRNA vaccine technology saved millions of lives during the Covid pandemic and received the 2023 Nobel Prize for Medicine
10.08.2025 00:26 — 👍 359 🔁 124 💬 3 📌 6
Reproducibility Project: Cancer Biology
Investigating reproducibility in preclinical cancer research.
Here's our attempt, which was (at minimum) much more transparent than the earlier Bayer and Amgen reports: elifesciences.org/collections/...
08.08.2025 16:18 — 👍 7 🔁 2 💬 1 📌 2
Terence Tao (@tao@mathstodon.xyz)
The current administration in the US has, through various funding agencies such as the NSF and NIH, has recently suspended virtually all federal grants to my home university, UCLA (including my own p...
Terence Tao (@teorth.bsky.social) has written a thread on Mastodon about the impact of the federal grant freeze to UCLA, particularly to his own field of Mathematics. UCLA's IPAM (Institute of Pure and Applied Mathematics) could shut down entirely
mathstodon.xyz/@tao/1149568...
02.08.2025 18:27 — 👍 293 🔁 134 💬 3 📌 15
The US is committing scientific suicide @kennethrmiller
12.07.2025 17:26 — 👍 17 🔁 4 💬 2 📌 0
A truly bizarre bit of news from an interview with Richard Saynor of Sandoz:
03.06.2025 16:29 — 👍 39 🔁 10 💬 2 📌 1
A New Route to Asthma Treatment - Through the Liver, of All Places
Animal models suggest that asthma might be treatable by delivering antigens directly to the liver (!)
02.06.2025 16:39 — 👍 41 🔁 11 💬 2 📌 2
The war on science in the US is already having an effect on private sector research like AlphaFold. Bears repeating but the private sector builds on top of things created by academic research for the public good. This hurts everyone.
28.05.2025 10:18 — 👍 240 🔁 106 💬 2 📌 12
Of note: this isn't describing theoretical imagined future state but the present, in an increasing number of care settings... ; FWIW most physicians I know who are using this seem to really appreciate it as Peter says. But will long-term effect be > time for doc/pt vs > push to see pts even faster?
28.05.2025 18:46 — 👍 2 🔁 1 💬 2 📌 0
We just released unmute.sh 🔇🔊
It is a text LLM wrapper, based on in-house streaming ASR, TTS, semantic VAD to reduce latency. ⏱️
Unlike Moshi 🟢, Unmute 🔊 is turn base, but allows customization in two clicks🖱️: voice and prompt!
Paper and open source coming soon.
23.05.2025 09:51 — 👍 9 🔁 1 💬 1 📌 0
Have you asked chatgpt ?
20.05.2025 18:09 — 👍 1 🔁 0 💬 0 📌 0
Mr. Secretary, Reclassify the Statin
One regulatory stroke could save more American lives than a decade of health campaigns. You have the pen.
Should low-dose statins be available OTC in the US? (UK did this in early 2000s!)
Read Alex Kesin’s case in favor: www.alexkesin.com/p/mr-secreta...
Thoughts from @cnewtoncheh.bsky.social, @ethanjweiss.bsky.social?
16.05.2025 10:07 — 👍 4 🔁 1 💬 1 📌 0
Interesting thing. She has this quote from Aristotle's politics, where she claims he says that with automation, we wouldn't need craftsmen, but would still need slaves. This is interestingly, so I looked it up. At least in Rackham's translation, Aristotle appears to literally say the opposite:
15.05.2025 15:05 — 👍 88 🔁 4 💬 5 📌 0
Nice transparency
15.05.2025 14:57 — 👍 1 🔁 0 💬 0 📌 0
A screenshot of the termination notice showing "Outstanding Investigator Grants"
A screenshot of the termination notice with "This award is terminated effective the date of this award, due to unsafe antisemitic actions that suggest the institution lacks concern for the safety and wellbeing of Jewish students." highlighted
Yesterday, the NIH R35 “Outstanding Investigator” grant to fund scientists in my lab studying antibiotic resistance was terminated for reasons not related to the content of the science, or any actions taken by me or members of my lab
13.05.2025 23:37 — 👍 881 🔁 582 💬 144 📌 73
Escape From the Lysosome
Two days in a row of antibody-drug conjugates! First, the thrilling lysosomal breakout:
13.05.2025 18:38 — 👍 21 🔁 5 💬 0 📌 0
New Cell Therapy For Resistant Hodkins Patients
And then we have this excellent new NK cell trial result for Hodgkin’s patients who are resistant to the existing ADC therapies (and all others). A real advance for people with no options left:
13.05.2025 18:42 — 👍 20 🔁 7 💬 1 📌 0
Single-cell proteomics is gaining momentum.
It can analyze the proteomes of ~ 1,000 single cells / day, and we need to ensure high quality cell isolation and sample preparation:
⬛️ These approaches can help:
nature.com/articles/s41...
09.05.2025 11:09 — 👍 23 🔁 5 💬 0 📌 1
The sample size calculation was based on the primary outcome assumption in the intervention and control groups, the severity level of ASD symptomatology, measured with the ADOS-CSS. In a previous study, the ADOS-CSS decreased in 62% of preschoolers whereas it was the same or worse in 37% of the children after 6 months of “as usual” treatment (42). Sample size calculations were performed using the nQuery advisor 6.2 software. Assuming a response rate of 62% in the placebo group and 90% in the probiotic group, it was calculated that 38 patients per treatment arm would be sufficient to achieve 90% power in detecting a treatment difference based on 1-tail χ2 test at a significance level of 0.05. The main statistical analysis included all participants who had data for the primary endpoint in the group to which they had originally been randomized. Analyses were performed both on the binary outcome measure assumed for sample size calculation (rates of subjects with a decrease in ADOS-CSS vs rates of subjects whereas it was the same or worse) and on continuous outcome measure (changes in mean ADOS-CSS).
A common story, where investigators needlessly shoot themselves in the foot when planning a trial:
1) They take a continuous outcome measure and dichotomize it to instead study % improved. This immediately tanks power by discarding information (turning a measure of rank and distance into a binary)
08.05.2025 10:04 — 👍 40 🔁 10 💬 4 📌 2
Research at risk: Life-saving heart pumps for babies | Cornell Chronicle
After receiving a stop-work order from the federal government, the future of a device to help children with heart defects is uncertain.
One of grants frozen at Cornell: $6.7M (4 yrs) to develop heart pumps for babies born w/ heart defects.
It took decades of work to get to point of prepping device for in-human clinical trials. No private company could do this.
The cruelty of the Trump administration is heartbreaking. So to speak.
07.05.2025 11:56 — 👍 3389 🔁 1784 💬 89 📌 157
Check out this great resource of single cell multiome data, cell annotations, regulatory DNA models of cell type resolved chromatin accessibility & comprehensive annotation of motifs & sequence syntax for multiple tissues in early human development 1/
04.05.2025 01:43 — 👍 72 🔁 14 💬 3 📌 0
I just got word that this federal transportation grant was terminated today, despite us removing the word "climate" from the title. The moral of the story? Obeying orders doesn't keep you safe with this administration.
02.05.2025 21:30 — 👍 872 🔁 312 💬 24 📌 9
ER doc, public health professional, researcher, and former chief medical officer at the CDC. Working to improve health in communities while figuring out what is next for me
Oncology trials and biostatistics https://scholar.google.co.uk/citations?user=ZbSK3WwAAAAJ
Biotech investor & board member | Covering biotech, drug development, venture capital, startups and pharma |📍New York
https://www.linkedin.com/in/rubensebastianperez/
My lab at Stanford studies human population genetics and complex traits.
Statistician and metascientist. Professor of biometrics at LMU Munich Medical and Mathematical Faculties, committed to open science, member of the Munich Center of Machine Learning. Opinions are mine.
Professor at EHESS & PSE
Co-Director, World Inequality Lab
inequalitylab.world | WID.world
http://piketty.pse.ens.fr/
Reader in Biostatistics, University of Liverpool
Professor, UW Biology / Santa Fe Institute
I study how information flows in biology, science, and society.
Book: *Calling Bullshit*, http://tinyurl.com/fdcuvd7b
LLM course: https://thebullshitmachines.com
Corvids: https://tinyurl.com/mr2n5ymk
he/him
Biostatistician and Associate Professor at the Australian Centre for Health Services Innovation QUT 🇦🇺 She/Her
Meta-research, infectious disease & acute care
We seek principles in the coordination among protein synthesis, metabolism, cell growth and differentiation. PI: @slavov-n.bsky.social
Web: https://slavovlab.net
Videos: http://youtube.slavovlab.net
All about Statistical Methods in Clinical Trials and Good Statistical Practice in Healthcare Research at Imperial Clinical Trials Unit (ICTU), Imperial College London #StatsCI
www.statsci.co.uk
Neuroscientist-cell biologist, proteomics developer, deep learning collaborator, tackling brain disorders. PI @Duke. Chair of Cell Biology and Biochem. Founder, Triangle Protein Design.
http://soderlinglab.cellbio.duke.edu
Chemist, Scientist, Husband, Dad, Runner, Teacher. I develop Avogadro + OpenBabel to find new materials for energy applications @Pitt_Chemistry he/him
Chemistry professor at CMU. Connecting chemical sciences with AI #MachineLearning and automated experimentation. #tarheels fan. Care: #design, #photography #Ukraine #cats🐈 Rants are mine
Co-founder & CEO of Hidden Door. I <3 cheeseburgers and making beautiful things. I know a thing or two about AI, but it's people who matter. I am interested in many things.
NYC
AI + Drug Discovery | Your front-row seat to the future of medicine
https://sprintome.substack.com
The account of MSF International 🌎
We've been providing independent, impartial, and neutral humanitarian medical care since 1971.
genetics/data/programming. ex-Hexagon, ex-Stanford ex-23andMe ex-TCD http://blog.booleanbiotech.com 🇮🇪
Chief Models Officer @ Stealth Startup; Inria & MVA - Ex: Llama @AIatMeta & Gemini and BYOL @GoogleDeepMind
GWAS whisperer.
It's usually the closest gene.
Executive Director, Integrative Biology, Internal Medicine Research Unit. Pfizer R&D. All views my own.
Also cats.